FDA Drug Recalls

Recalls / Class III

Class IIID-0998-2017

Product

Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed by OMP, Inc., Long Beach, CA Made in USA, NDC 62032-222-02

Affected lot / code info
Lot #: 2578400, 0Exp 8/2019

Why it was recalled

Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

Recalling firm

Firm
Valeant Pharmaceuticals North America LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
400 Somerset Corporate Blvd, N/A, Bridgewater, New Jersey 08807-2867

Distribution

Quantity
844 bottles
Distribution pattern
U.S. Nationwide

Timeline

Recall initiated
2017-06-28
FDA classified
2017-07-14
Posted by FDA
2017-07-26
Terminated
2018-01-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0998-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls